Treatment of chronic hepatitis C with pegylated interferon alfa-2a plus ribavirin in hemophiliac patients

被引：0
|
作者：
Malekzadeh, R
Merat, S
Sohrabpour, AA
Khaleghi, S
Samimi-Rad, K
机构：
来源：
GASTROENTEROLOGY | 2004年 / 126卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A431 / A431
页数：1
相关论文
共 50 条
  • [31] Ribavirin Impairs Salivary Gland Function in Hepatitis C Patients During Combination Treatment With Pegylated Interferon Alfa-2a
    Aghemo, Alessio
    Rumi, Maria Grazia
    Monico, Sara
    Banderali, Matteo
    Russo, Antonio
    Ottaviani, Francesco
    Vigano, Mauro
    D'Arnbrosio, Roberta
    Colombo, Massimo
    HEPATITIS MONTHLY, 2011, 11 (11) : 919 - 925
  • [32] Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial
    Fabrizio Mecenate
    Adriano M Pellicelli
    Giuseppe Barbaro
    Mario Romano
    Angelo Barlattani
    Ettore Mazzoni
    Maria Elena Bonaventura
    Lorenzo Nosotti
    Pasquale Arcuri
    Antonio Picardi
    Giorgio Barbarini
    Cecilia D'Ambrosio
    Amerigo Paffetti
    Arnaldo Andreoli
    Fabrizio Soccorsi
    BMC Gastroenterology, 10
  • [33] Pegylated interferon alfa and ribavirin for children with chronic hepatitis C
    Rosen, Irit
    Kori, Michal
    Adiv, Orly Eshach
    Yerushalmi, Baruch
    Zion, Nataly
    Shaoul, Ron
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (07) : 1098 - 1103
  • [34] Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial
    Mecenate, Fabrizio
    Pellicelli, Adriano M.
    Barbaro, Giuseppe
    Romano, Mario
    Barlattani, Angelo
    Mazzoni, Ettore
    Bonaventura, Maria Elena
    Nosotti, Lorenzo
    Arcuri, Pasquale
    Picardi, Antonio
    Barbarini, Giorgio
    D'Ambrosio, Cecilia
    Paffetti, Amerigo
    Andreoli, Arnaldo
    Soccorsi, Fabrizio
    BMC GASTROENTEROLOGY, 2010, 10
  • [35] Pegylated interferon plus ribavirin in chronic hepatitis c
    Bruce R. Bacon
    Current Gastroenterology Reports, 2001, 3 (1) : 84 - 84
  • [36] Pegylated interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4 in adolescents
    Al Ali, Jaber
    Owayed, Salem
    Al-Qabandi, Wafa'a
    Husain, Khaled
    Hasan, Fuad
    ANNALS OF HEPATOLOGY, 2010, 9 (02) : 156 - 160
  • [37] PEGYLATED INTERFERON ALPHA PLUS RIBAVIRIN TREATMENT OF CHRONIC HEPATITIS C IN PSORIATIC PATIENTS
    Tomasiewicz, Krzysztof
    Modrzewska, Romana
    HEPATOLOGY, 2008, 48 (04) : 907A - 907A
  • [38] Association of Host Pharmacodynamic Effects with Virologic Response to Pegylated Interferon alfa-2a/Ribavirin in Chronic Hepatitis C
    Chung, Raymond T.
    Poordad, Fred F.
    Hassanein, Tarek
    Zhou, Xiaolei
    Lentz, Ellen
    Prabhakar, Avinash
    Di Bisceglie, Adrian M.
    HEPATOLOGY, 2010, 52 (06) : 1906 - 1914
  • [39] Comparison of Sofosbuvir Plus Ribavirin Treatment with Pegylated Interferon Plus Ribavirin Treatment for Chronic Hepatitis C Genotype 2
    Seo, Kayo
    Kim, Soo Ki
    Kim, Soo Ryang
    Ohtani, Aya
    Kobayashi, Mana
    Kato, Airi
    Morimoto, Eri
    Saijo, Yuka
    Kim, Ke Ih
    Imoto, Susumu
    Kim, Chi Wan
    Yano, Yoshihiko
    Kudo, Masatoshi
    Hayashi, Yoshitake
    DIGESTIVE DISEASES, 2017, 35 (06) : 541 - 547
  • [40] Pegylated interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients.
    Garcia-Samaniego, J
    Romero, M
    Pérez-Olmeda, M
    Barreiro, P
    Nuñez, M
    Soriano, V
    HEPATOLOGY, 2001, 34 (04) : 580A - 580A
12345